Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Material Review Agility is the Game Changer for Rapid Compliance in the Pharmaceutical Industry

Material review agility is becoming essential in the pharmaceutical industry for meeting regulatory compliance swiftly. The latest insights from Vodori highlight the importance of adapting strategies to enhance the material review process. Companies must leverage technology and strategic planning to keep pace with regulatory changes.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Vodori on MarketScale.

By Annalise Ludtke · 6 Tangerines ConsultingAnne SwearingenBenchmark SymposiumPharmaceutical Industry
Share
Material Review Agility is the Game Changer for Rapid Compliance in the Pharmaceutical Industry

Key takeaways

01

Material review agility is crucial for quick compliance in the pharmaceutical industry.

02

Strategic planning and technology are necessary to adapt to regulatory demands.

03

Engagement and clear communication are key for process efficiency.

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Material review agility is at the forefront of the latest episode of the Benchmarks Symposium, where Annalise Ludtke, the Senior Manager of Marketing and Communications at Vodori and Anne Swearingen, the CEO at 6 Tangerines Consulting dive into the evolving landscape of promotional review processes within the pharmaceutical industry. They emphasize the importance of agility amidst the digital shift and resource constraints highlighted in Vodori's 2023 State of Promotional Review Benchmarks report. The discussion points towards the necessity for companies to adapt swiftly and plan strategically to keep pace with the rapid changes and regulatory demands that define today's market, underscoring the challenges of digital content creation and the need for compliance and efficiency.

The discussion points towards the necessity for companies to adapt swiftly and plan strategically to keep pace with the rapid changes and regulatory demands that define today's market.

The conversation also brings to light practical strategies for enhancing the efficiency of the material review process, such as engaging stakeholders early, employing clear communication, and leveraging technological solutions like PepperFlow to facilitate smoother reviews. Swearingen's insights into categorizing tasks by complexity and the use of pre-approved content underscore the potential for significantly improving process efficiency. This episode underlines the indispensable nature of material review agility in effectively navigating the complexities of the pharmaceutical industry's regulatory environment, offering valuable guidance for those aiming to refine their promotional content review processes through agility, strategic foresight, and collaborative effort.

Material review agility is indispensable in effectively navigating the complexities of the pharmaceutical industry's regulatory environment.

Vodori

Part of this channel

Vodori

Faster market access through compliant life science content review.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

AL
Annalise Ludtke

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

Value-based care reaches a quarter of revenue at 30% of surveyed health organizations

Value-based care reaches a quarter of revenue at 30% of surveyed health organizations

Wolters Kluwer Health argues value-based care software is judged on whether customers hit incentive thresholds and avoid penalties. A Fierce Healthcare-reported survey it cites puts value-based care at a quarter or more of revenue for 30% of organizations. The analysis is a vendor publication that ends by pitching its own UpToDate Connect API.

  • 01The sharper question for any population health or care coordination platform is whether it changes what a clinician does at the moment of decision, or only reports afterward what happened. Wolters Kluwer's reading of the evidence is that many platforms still struggle with the first.
  • 02Vendors selling into value-based contracts now face a build-or-license decision on clinical content, because Wolters Kluwer names current, trusted content, consistent clinician adoption across sites, and a traceable link from guidance to quality metrics as the three hard problems.

Sep 18, 2026

Hospitals lost money on telehealth with every payer type in 2025

Strata Decision Technology's Performance Trends report found telehealth encounters at U.S. hospitals rose 79% from January 2019 to January 2026, yet average total cost margins were negative for commercial, Medicare, Medicaid and self-pay patients in 2025. Adoption has outrun reimbursement. The gap lands on health systems that posted a 0.2% operating margin in April, according to Strata.

  • 01A negative total cost margin on telehealth across all four payer categories is now a national benchmark from a dataset covering more than 2,200 hospitals; a health system's own per-encounter virtual care margin can be measured against it.
  • 02Remote patient monitoring encounters grew nearly 4,000% since 2019 while reimbursement for the service is still maturing, so an RPM business case built on volume alone will miss the number that actually decides its viability.
  • 03The signal to watch is whether any single payer category shows a positive telehealth margin in Strata's next Performance Trends cut. As of the 2025 data, none did.

Sep 18, 2026

Most reprocessing audit gaps trace back to training, turnover and leadership

Most reprocessing audit gaps trace back to training, turnover and leadership

Joint Commission findings on its reprocessing standard point mostly to training, turnover, leadership and missing ownership, not sterilizers. CDC epidemiologists and a 2019 review add cleaning verification and manufacturer instructions as the steps to watch. Audit people and process steps as closely as the autoclave.

  • 01Of the Joint Commission's list of reasons hospitals miss reprocessing standard IC.02.02.01, at least eight concern people, priorities and management, so competency records and a named process owner belong in the audit as much as sterilizer logs.
  • 02A structured audit tool that scores compliance step by step, as a 2020 BMC Health Services Research study did across 189 reprocessing cycles, shows where training hours should go; the Nepal hospitals scored best on cleaning and storage and worse on the steps between.

Sep 14, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Experts

AL
Annalise Ludtke

Senior Manager of Marketing and Communications at Vodori

Annalise Ludtke is a seasoned marketing professional currently serving as the Senior Manager of Marketing and Communications at Vodori. She specializes in promoting agility within compliance processes, leveraging her expertise to help pharmaceutical companies navigate complex regulatory environments.

AS
Anne Swearingen

CEO

6 Tangerines Consulting

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512